Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right …
This position paper provides a comprehensive guide for optimal follow-up of patients with
acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It …
acute pulmonary embolism (PE), covering multiple relevant aspects of patient counselling. It …
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
FA Klok, MV Huisman - Blood, The Journal of the American …, 2020 - ashpublications.org
For patients with venous thromboembolism (VTE), prediction of bleeding is relevant
throughout the course of treatment, although the means and goal of this prediction differ …
throughout the course of treatment, although the means and goal of this prediction differ …
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
Aims The aim of this study is to compare the Hestia rule vs. the simplified Pulmonary
Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) …
Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) …
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism
CMM de Jong, M Blondon, C Ay… - Blood, The Journal …, 2022 - ashpublications.org
Preliminary data and clinical experience have suggested an increased risk of abnormal
uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid …
uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid …
[HTML][HTML] Venous thromboembolism issues in women
B Linnemann, H Rott, R Zotz, C Hart - Hämostaseologie, 2022 - thieme-connect.com
The lifetime risk of venous thromboembolism (VTE) is slightly higher in women than in men.
There are several issues related to VTE that are unique to women. Combined hormonal …
There are several issues related to VTE that are unique to women. Combined hormonal …
Which hormones and contraception for women with APS? Exogenous hormone use in women with APS
LR Sammaritano - Current Rheumatology Reports, 2021 - Springer
Abstract Purpose of Review Use of exogenous estrogen carries significant risk for patients
with prothrombotic disorders including those with antiphospholipid antibody (aPL) and …
with prothrombotic disorders including those with antiphospholipid antibody (aPL) and …
Hormones and thrombosis: risk across the reproductive years and beyond
N Machin, MV Ragni - Translational Research, 2020 - Elsevier
Endogenous and exogenous hormones have significant effects on coagulation and may tip
the hemostatic balance toward thrombosis. The endogenous hormonal changes in …
the hemostatic balance toward thrombosis. The endogenous hormonal changes in …
[HTML][HTML] Portal venous thrombosis associated with use of etonogestrel/ethinyl estradiol vaginal ring
KE Bailey, MJ Tranovich - Clinical Practice and Cases in …, 2020 - ncbi.nlm.nih.gov
Discussion Women using hormonal contraception are approximately four times more likely
to develop thromboembolism. Risk of thromboembolism is similar between users of …
to develop thromboembolism. Risk of thromboembolism is similar between users of …
Контрацепция при антифосфолипидном синдроме и системной красной волчанке (по рекомендациям Европейского альянса ревматологических ассоциаций …
ТМ Решетняк, СБ Керчелаева… - Научно-практическая …, 2024 - rsp.mediar-press.net
Аннотация Одной из первостепенных задач общества является сохранение и
укрепление здоровья нации. Недостаточное понимание важности вопросов …
укрепление здоровья нации. Недостаточное понимание важности вопросов …
Perioperative venous thromboembolism risk considerations in the gender diverse patient–Should we consider more than just estrogen?
LY Jenny, M Lane, GD Roach… - Thrombosis …, 2023 - thrombosisresearch.com
A 20-year-old assigned female at birth (AFAB) transmasculine individual was evaluated to
undergo gender-affirming mastectomy. He was on oral ethynodiol-ethinyl estradiol (a …
undergo gender-affirming mastectomy. He was on oral ethynodiol-ethinyl estradiol (a …